Great Lakes Advisors’s IGM Biosciences IGMS Stock Holding History

Great Lakes Advisors’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-21,765	Closed	-$1.92M	–	717
2020 Q4	$1.92M	Buy	+21,765	New	+$1.53M	0.03%	365

Other funds holding IGMS

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Great Lakes Advisors's IGMS Position: Q1 2021 in Review

Great Lakes Advisors sold out of IGM Biosciences (IGMS) in Q1 2021, closing a stake of 21,765 shares — an estimated $1.92M sold.

Great Lakes Advisors first reported a position in IGMS in Q4 2020 and held it in 1 quarter. The position peaked at $1.92M in Q4 2020. 109 funds tracked by Wall St. Rank hold IGMS as of Q1 2021.

Great Lakes Advisors reported no remaining IGM Biosciences position as of Q1 2021 after selling out during the quarter.
Great Lakes Advisors sold 21,765 IGM Biosciences shares in Q1 2021, an estimated $1.92M.
Great Lakes Advisors first reported a position in IGM Biosciences in Q4 2020 and held it in 1 quarter.
Great Lakes Advisors's IGM Biosciences position peaked at $1.92M in Q4 2020.
109 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2021.

Based on Great Lakes Advisors's 13F filing for Q1 2021, filed 3 May 2021.